Literature DB >> 15002397

Coagulation disorders in patients with cirrhosis and severe sepsis.

Aurélie Plessier1, Marie-Hélène Denninger, Yann Consigny, Fabienne Pessione, Claire Francoz, François Durand, Sven Francque, Annie Bezeaud, Laurence Chauvelot-Moachon, Didier Lebrec, Dominique-Charles Valla, Richard Moreau.   

Abstract

BACKGROUND: In patients with cirrhosis, severe sepsis may stimulate the extrinsic coagulation pathway resulting in thrombin generation and fibrin formation. AIMS: To compare 23 patients with severe sepsis to 13 infected patients without severe sepsis and 18 patients without infection.
METHODS: Zymogen forms of clotting factors involved in the extrinsic pathway (i.e., factors VII + X, V, prothrombin), and the presence of soluble fibrin were assessed.
RESULTS: Zymogen forms of clotting factors were significantly lower, while Child-Pugh score and the proportion of patients with soluble fibrin were higher in the severe-sepsis group than in the other groups. Decreased zymogen levels were independently correlated with an elevated Child-Pugh score and the presence of severe sepsis. In the severe-sepsis group, after adjustment for the severity of cirrhosis, decreased zymogen levels were associated with significant increases in the relative risk ratios of in-hospital death.
CONCLUSIONS: Cirrhotic patients with severe sepsis have decreased blood levels of zymogen forms of factors VII+X, V, and prothrombin, which may be due not only to the severity of cirrhosis but also, at least in part, to the consumption of these zymogens by the extrinsic coagulation pathway.

Entities:  

Mesh:

Year:  2003        PMID: 15002397     DOI: 10.1111/j.1478-3231.2003.00870.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  24 in total

1.  Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis.

Authors:  Chalermrat Bunchorntavakul; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2012-05-27

Review 2.  Gut flora and bacterial translocation in chronic liver disease.

Authors:  John Almeida; Sumedha Galhenage; Jennifer Yu; Jelica Kurtovic; Stephen M Riordan
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

3.  Scoring system for traumatic liver injury (SSTLI) in polytraumatic patients: a predictor of mortality.

Authors:  H H Kim; J H Kim; C-Y Park; H M Cho
Journal:  Eur J Trauma Emerg Surg       Date:  2014-10-21       Impact factor: 3.693

Review 4.  Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club.

Authors:  F Wong; M Bernardi; R Balk; B Christman; R Moreau; G Garcia-Tsao; D Patch; G Soriano; J Hoefs; M Navasa
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

5.  Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor.

Authors:  Dagmar Kubitza; Angelika Roth; Michael Becka; Abir Alatrach; Atef Halabi; Holger Hinrichsen; Wolfgang Mueck
Journal:  Br J Clin Pharmacol       Date:  2013-07       Impact factor: 4.335

Review 6.  Spontaneous bacterial peritonitis: from pathophysiology to prevention.

Authors:  Mauro Bernardi
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

7.  Diagnosis and therapy of ascites in liver cirrhosis.

Authors:  Erwin Biecker
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

8.  The new epidemiology of nosocomial bacterial infections in cirrhosis: therapeutical implications.

Authors:  Juan Acevedo; Aníbal Silva; Verónica Prado; Javier Fernández
Journal:  Hepatol Int       Date:  2012-08-14       Impact factor: 6.047

9.  Endothelial cell injury with inflammatory cytokine and coagulation in patients with sepsis.

Authors:  Huan Ding; Xiang-Yuan Cao; Xi-Gang Ma; Wen-Jie Zhou
Journal:  World J Emerg Med       Date:  2013

10.  Microbial translocation in chronic liver diseases.

Authors:  Marilia Rita Pinzone; Benedetto Maurizio Celesia; Michele Di Rosa; Bruno Cacopardo; Giuseppe Nunnari
Journal:  Int J Microbiol       Date:  2012-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.